HEADER OXYGEN TRANSPORT 15-OCT-97 1AXF OBSLTE 21-DEC-04 1AXF 1Y85 TITLE HEMOGLOBIN MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: DESHIS DEOXYHEMOGLOBIN A; COMPND 3 CHAIN: A, C; COMPND 4 MUTATION: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: DESHIS DEOXYHEMOGLOBIN A; COMPND 7 CHAIN: B, D; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGAN: BLOOD; SOURCE 5 TISSUE: BLOOD; SOURCE 6 CELL: RED BLOOD CELL; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGAN: BLOOD; SOURCE 11 TISSUE: BLOOD; SOURCE 12 CELL: RED BLOOD CELL KEYWDS OXYGEN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR J.S.KAVANAUGH,A.ARNONE REVDAT 1 28-JAN-98 1AXF 0 JRNL AUTH S.BETTATI,L.D.KWIATKOWSKI,J.S.KAVANAUGH, JRNL AUTH 2 A.MOZZARELLI,A.ARNONE,G.L.ROSSI,R.W.NOBLE JRNL TITL STRUCTURE AND OXYGEN AFFINITY OF CRYSTALLINE JRNL TITL 2 DES-HIS-146BETA HUMAN HEMOGLOBIN IN THE T STATE. JRNL REF J.BIOL.CHEM. V. 272 33077 1997 JRNL REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.S.KAVANAUGH,P.H.ROGERS,D.A.CASE,A.ARNONE REMARK 1 TITL HIGH-RESOLUTION X-RAY STUDY OF DEOXYHEMOGLOBIN REMARK 1 TITL 2 ROTHSCHILD 37 BETA TRP----ARG: A MUTATION THAT REMARK 1 TITL 3 CREATES AN INTERSUBUNIT CHLORIDE-BINDING SITE REMARK 1 REF BIOCHEMISTRY V. 31 4111 1992 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 34083 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1740 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 35209 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4364 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 172 REMARK 3 SOLVENT ATOMS : 149 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.010 ; 0.010 REMARK 3 ANGLE DISTANCE (A) : 0.025 ; 0.015 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.040 ; 0.030 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.011 ; 0.010 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.133 ; 0.080 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.161 ; 0.200 REMARK 3 MULTIPLE TORSION (A) : 0.174 ; 0.200 REMARK 3 H-BOND (X...Y) (A) : 0.168 ; 0.200 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 2.500 ; 5.000 REMARK 3 STAGGERED (DEGREES) : 20.200; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 32.000; 25.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.000 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.200 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 7.600 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 10.500; 6.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STARTING MODEL FOR REFINEMENT REMARK 3 WAS PDB1HHB.ENT REMARK 4 REMARK 4 1AXF COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 6 REMARK 6 THE COORDINATES GIVEN HERE ARE IN THE ORTHOGONAL ANGSTROM REMARK 6 SYSTEM THAT IS STANDARD FOR TETRAMERIC HEMOGLOBINS. THE Y REMARK 6 AXIS IS A NONCRYSTALLOGRAPHIC MOLECULAR DIAD, AND THE X REMARK 6 AXIS IS A PSEUDO DIAD THAT RELATES THE ALPHA-1 SUBUNIT TO REMARK 6 THE BETA-1 SUBUNIT (AND ALPHA-2 TO BETA-2). REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JAN-1996 REMARK 200 TEMPERATURE (KELVIN) : 295.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU/MSC RU-H2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : MULTIWIRE AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : XUONG-HAMLIN MULTIWIRE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SDMS REMARK 200 DATA SCALING SOFTWARE : SDMS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35576 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : 0.09000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.22400 REMARK 200 R SYM FOR SHELL (I) : 0.22400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.980 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: ISOMORPHOUS WITH REMARK 200 DEOXYHEMOGLOBIN A REMARK 200 SOFTWARE USED: PROLSQ REMARK 200 STARTING MODEL: PDB ENTRY 1HHB REMARK 200 REMARK 200 REMARK: PDB ENTRY 1HHB WAS USED AS THE STARTING MODEL FOR LEAST REMARK 200 -SQUARES REFINEMENT REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 1/2-X,1/2+Y,-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 0.530814 0.391826 0.751434 0.00000 REMARK 290 SMTRY2 2 0.391849 -0.899703 0.192348 0.00000 REMARK 290 SMTRY3 2 0.751496 0.192353 -0.631111 0.00000 REMARK 290 SMTRY1 3 -0.545085 -0.232420 -0.805482 27.73031 REMARK 290 SMTRY2 3 -0.232409 -0.881260 0.411508 -57.88803 REMARK 290 SMTRY3 3 -0.805562 0.411568 0.426345 -26.30689 REMARK 290 SMTRY1 4 -0.985729 -0.159407 0.054049 27.73031 REMARK 290 SMTRY2 4 -0.159440 0.780963 -0.603856 -57.88803 REMARK 290 SMTRY3 4 0.054066 -0.603921 -0.795234 -26.30689 REMARK 290 REMARK 290 REMARK: NULL REMARK 295 REMARK 295 NON-CRYSTALLOGRAPHIC SYMMETRY REMARK 295 THE TRANSFORMATIONS PRESENTED ON THE MTRIX RECORDS BELOW REMARK 295 DESCRIBE NON-CRYSTALLOGRAPHIC RELATIONSHIPS AMONG ATOMS REMARK 295 IN THIS ENTRY. APPLYING THE APPROPRIATE MTRIX REMARK 295 TRANSFORMATION TO THE RESIDUES LISTED FIRST WILL YIELD REMARK 295 APPROXIMATE COORDINATES FOR THE RESIDUES LISTED SECOND. REMARK 295 CHAIN IDENTIFIERS GIVEN AS "?" REFER TO CHAINS FOR WHICH REMARK 295 ATOMS ARE NOT FOUND IN THIS ENTRY. REMARK 295 REMARK 295 APPLIED TO TRANSFORMED TO REMARK 295 TRANSFORM CHAIN RESIDUES CHAIN RESIDUES RMSD REMARK 295 SSS REMARK 295 M 1 A 1 .. 141 C 1 .. 141 0.318 REMARK 295 M 2 B 1 .. 145 D 1 .. 145 0.372 REMARK 295 REMARK 295 WHERE SSS -> COLUMNS 8-10 OF MTRIX RECORDS REMARK 295 REMARK 295 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 4 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 999 REMARK 999 SEQUENCE REMARK 999 1AXF B SWS P02023 146 - 146 NOT IN ATOMS LIST REMARK 999 1AXF D SWS P02023 146 - 146 NOT IN ATOMS LIST REMARK 999 REMARK 999 HIS 146 IN CHAINS B AND D WAS DELETED BY MUTATION. DBREF 1AXF A 1 141 UNP P01922 HBA_HUMAN 1 141 DBREF 1AXF B 1 145 UNP P02023 HBB_HUMAN 1 145 DBREF 1AXF C 1 141 UNP P01922 HBA_HUMAN 1 141 DBREF 1AXF D 1 145 UNP P02023 HBB_HUMAN 1 145 SEQRES 1 A 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 A 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 A 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 A 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 A 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 A 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 A 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 A 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 A 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 A 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 A 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 145 VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 B 145 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 B 145 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 145 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 B 145 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 B 145 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 B 145 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 B 145 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 B 145 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 B 145 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 B 145 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 B 145 LYS TYR SEQRES 1 C 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 C 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 C 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 C 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 C 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 C 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 C 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 C 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 C 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 C 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 C 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 D 145 VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 D 145 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 D 145 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 145 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 D 145 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 D 145 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 D 145 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 D 145 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 D 145 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 D 145 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 D 145 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 D 145 LYS TYR HET HEM A 142 43 HET HEM B 147 43 HET HEM C 142 43 HET HEM D 147 43 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 5 HEM 4(C34 H32 FE N4 O4) FORMUL 9 HOH *149(H2 O1) HELIX 1 1 PRO A 4 SER A 35 1 32 HELIX 2 2 PRO A 37 TYR A 42 5 6 HELIX 3 3 ALA A 53 ALA A 71 1 19 HELIX 4 4 MET A 76 ALA A 79 1 4 HELIX 5 5 SER A 81 HIS A 89 1 9 HELIX 6 6 PRO A 95 HIS A 112 5 18 HELIX 7 7 PRO A 119 LEU A 136 1 18 HELIX 8 8 PRO B 5 LYS B 17 1 13 HELIX 9 9 VAL B 20 VAL B 34 1 15 HELIX 10 10 PRO B 36 PHE B 41 5 6 HELIX 11 11 GLU B 43 PHE B 45 5 3 HELIX 12 12 PRO B 51 MET B 55 1 5 HELIX 13 13 PRO B 58 ALA B 76 1 19 HELIX 14 14 LEU B 81 ASP B 94 1 14 HELIX 15 15 PRO B 100 GLU B 121 5 22 HELIX 16 16 PRO B 124 ALA B 142 1 19 HELIX 17 17 PRO C 4 SER C 35 1 32 HELIX 18 18 PRO C 37 TYR C 42 5 6 HELIX 19 19 ALA C 53 ALA C 71 1 19 HELIX 20 20 MET C 76 ALA C 79 1 4 HELIX 21 21 SER C 81 HIS C 89 1 9 HELIX 22 22 PRO C 95 HIS C 112 5 18 HELIX 23 23 PRO C 119 THR C 137 1 19 HELIX 24 24 PRO D 5 LYS D 17 1 13 HELIX 25 25 VAL D 20 VAL D 34 1 15 HELIX 26 26 PRO D 36 PHE D 41 5 6 HELIX 27 27 GLU D 43 PHE D 45 5 3 HELIX 28 28 PRO D 51 GLY D 56 1 6 HELIX 29 29 PRO D 58 ALA D 76 1 19 HELIX 30 30 LEU D 81 THR D 84 1 4 HELIX 31 31 ALA D 86 ASP D 94 1 9 HELIX 32 32 PRO D 100 GLU D 121 5 22 HELIX 33 33 PRO D 124 ALA D 142 1 19 LINK FE HEM A 142 NE2 HIS A 87 LINK FE HEM B 147 NE2 HIS B 92 LINK FE HEM C 142 NE2 HIS C 87 LINK FE HEM D 147 NE2 HIS D 92 CRYST1 97.100 99.100 66.000 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.000870 -0.009718 0.003295 0.21203 SCALE2 0.004813 -0.002459 -0.008522 0.26491 SCALE3 0.013256 0.003393 0.006507 -0.23517 MTRIX1 1 -1.000000 0.000000 0.000000 0.00000 1 MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 1 0.000000 0.000000 -1.000000 0.00000 1 MTRIX1 2 -1.000000 0.000000 0.000000 0.00000 1 MTRIX2 2 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 2 0.000000 0.000000 -1.000000 0.00000 1